Advanced Biomed Inc. 8-K

What Happened
Advanced Biomed Inc. announced it entered into a Loan Agreement with Jie Wang on April 13, 2026, under which the lender advanced US$600,000 to the company. The loan bears interest at 10% per year, accrues from disbursement, and has a six‑month term from the disbursement date (with a mutual option to extend for an additional six months). The company may prepay the loan without penalty, and the loan is unsecured. The 8‑K was filed April 14, 2026.

Key Details

• Loan principal: US$600,000.
• Interest rate and term: 10% per annum; six‑month maturity with possible six‑month extension.
• Security and repayment: Unsecured; prepayment allowed without penalty; full principal and accrued interest due by maturity.
• Use of proceeds: for company operations.

Why It Matters
This agreement provides near‑term liquidity to support Advanced Biomed’s operations but creates a short‑term repayment obligation and additional interest expense. The unsecured, relatively high‑rate loan suggests the company sought quick funding without pledging assets; investors should note the six‑month maturity (or up to 12 months if extended), which may require the company to refinance, repay from cash flow, or otherwise manage its cash runway.